STOCK TITAN

Context Therapeutics (CNTX): Octagon group reports 3.3% beneficial stake in Schedule 13G/A

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Context Therapeutics Inc. has a group of institutional investors reporting a passive ownership position. Octagon Capital Advisors LP, Octagon Investments Master Fund LP, and Ting Jia as control person collectively report beneficial ownership of 3,050,000 shares of Context Therapeutics common stock, representing 3.3% of the class.

All 3,050,000 shares are held by Octagon Investments Master Fund and are subject to shared voting and dispositive power; the reporting persons have no sole voting or dispositive power. The ownership percentage is based on 91,879,177 common shares outstanding as of April 27, 2026, as reported by the issuer. The filing states that the Master Fund holds the shares for the benefit of its investors, with Octagon as investment advisor and Ting Jia as control person.

Positive

  • None.

Negative

  • None.
Shares beneficially owned 3,050,000 shares Common stock beneficially owned by the reporting persons
Ownership percentage 3.3% Percentage of Context Therapeutics common stock class
Shares outstanding baseline 91,879,177 shares Common shares outstanding as of April 27, 2026
Sole voting power 0 shares Shares with sole voting power reported by the group
Shared voting power 3,050,000 shares Shares with shared voting power reported by the group
beneficially own financial
"may be deemed to beneficially own the Issuer's Common Shares"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
shared voting power financial
"Shared Voting Power 3,050,000.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
dispositive power financial
"Shared Dispositive Power 3,050,000.00"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
control person financial
"Dr. Jia is the control person of Octagon."
A control person is an individual or entity that can significantly influence a company’s decisions and direction through ownership, voting power, or contractual rights—think of them as the captain who can steer the ship. Investors care because a control person’s choices affect corporate strategy, board appointments, and transactions that can raise or lower a stock’s value, and they often carry additional legal responsibilities and disclosure requirements to protect other shareholders.
Schedule 13G regulatory
"The percentage reported on this is calculated based upon 91,879,177"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What percentage of Context Therapeutics (CNTX) does Octagon Capital Advisors report owning?

Octagon Capital Advisors, its Master Fund, and Ting Jia collectively report beneficial ownership of 3.3% of Context Therapeutics’ common stock, based on 91,879,177 shares outstanding as of April 27, 2026.

Do the Octagon reporting persons have sole or shared voting power over CNTX shares?

They report 0 shares with sole voting power and 3,050,000 shares with shared voting power. The same figures apply to dispositive power, indicating decisions are made jointly rather than individually.

On what share count is the 3.3% CNTX ownership calculation based?

The 3.3% ownership is calculated using 91,879,177 Context Therapeutics common shares outstanding as of April 27, 2026, a figure reported by the issuer in a Form 8-K filed on June 26, 2026.

Who ultimately benefits from the CNTX shares held by Octagon Investments Master Fund?

The Master Fund holds the Context Therapeutics common shares for the benefit of its investors. Octagon acts as investment advisor, and Ting Jia is the control person of Octagon with indirect beneficial ownership.





21077P108

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Octagon Capital Advisors LP
Signature:/s/ Ting Jia
Name/Title:Managing Member
Date:07/31/2026
Octagon Investments Master Fund LP
Signature:/s/ Ting Jia
Name/Title:Managing Member, Octagon Investments GP, LLC, its general partner
Date:07/31/2026
Ting Jia
Signature:/s/ Ting Jia
Name/Title:Ting Jia
Date:07/31/2026